title: Optimizing the Safe Use of Direct Oral Anticoagulants in Older Patients: A Teachable Moment.
authors.affiliation: Clinical Pharmacy Research Group, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium2Namur Thrombosis and Hemostasis Center, Namur, Belgium.
authors.forename: Anne-Laure
authors.initials: AL
authors.lastname: Sennesael
authors.affiliation: Namur Thrombosis and Hemostasis Center, Namur, Belgium3Department of Pharmacy, Namur Research Institute for Life Sciences, University of Namur, Namur, Belgium.
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Dogné
authors.affiliation: Clinical Pharmacy Research Group, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium2Namur Thrombosis and Hemostasis Center, Namur, Belgium4Department of Pharmacy, CHU Dinant Godinne UcL Namur, Université catholique de Lo.
authors.forename: Anne
authors.initials: A
authors.lastname: Spinewine
mesh_terms: D000074:Acenocoumarol / Q000008:administration & dosage / Q000009:adverse effects; D000284:Administration, Oral; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy; D016903:Drug Monitoring; D057915:Drug Substitution / Q000379:methods; D004844:Epistaxis / Q000209:etiology / Q000517:prevention & control; D065427:Factor Xa Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D016330:Frail Elderly; D006801:Humans; D054539:Medication Therapy Management; D058729:Peripheral Arterial Disease / Q000150:complications / Q000188:drug therapy; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D051437:Renal Insufficiency / Q000150:complications*; D000069552:Rivaroxaban / Q000008:administration & dosage / Q000009:adverse effects; D020521:Stroke / Q000209:etiology / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D010975:Platelet Aggregation Inhibitors; D000069552:Rivaroxaban; D000074:Acenocoumarol; D001241:Aspirin